Dimensional Fund Advisors
KYMR icon

Dimensional Fund Advisors’s Kymera Therapeutics KYMR Stock Holding History

Dimensional Fund Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.4M Sell
592,879
-31,148
-5% -$2.47M 0.01% 1504
2025
Q4 		$48.6M Sell
624,027
-107,393
-15% -$7.25M 0.01% 1524
2025
Q3 		$41.4M Buy
731,420
+168,055
+30% +$7.58M 0.01% 1621
2025
Q2 		$24.6M Buy
563,365
+167,897
+42% +$5.78M 0.01% 1871
2025
Q1 		$10.8M Sell
395,468
-38,287
-9% -$1.4M ﹤0.01% 2218
2024
Q4 		$17.4M Sell
433,755
-38,871
-8% -$1.76M ﹤0.01% 2051
2024
Q3 		$22.4M Buy
472,626
+70,241
+17% +$3.1M 0.01% 1953
2024
Q2 		$12M Buy
402,385
+53,176
+15% +$1.84M ﹤0.01% 2182
2024
Q1 		$14M Sell
349,209
-184,514
-35% -$6.6M ﹤0.01% 2165
2023
Q4 		$13.6M Sell
533,723
-121,504
-19% -$2.17M ﹤0.01% 2179
2023
Q3 		$9.11M Sell
655,227
-185,711
-22% -$3.73M ﹤0.01% 2312
2023
Q2 		$19.3M Buy
840,938
+100,947
+14% +$2.89M 0.01% 1949
2023
Q1 		$21.9M Buy
739,991
+426,831
+136% +$13.8M 0.01% 1854
2022
Q4 		$7.82K Buy
313,160
+100,795
+47% +$2.69M ﹤0.01% 2311
2022
Q3 		$4.62M Buy
212,365
+25,084
+13% +$661K ﹤0.01% 2452
2022
Q2 		$3.69M Sell
187,281
-50,450
-21% -$1.18M ﹤0.01% 2544
2022
Q1 		$10.1M Buy
237,731
+172,839
+266% +$7.3M ﹤0.01% 2298
2021
Q4 		$4.12M Buy
+64,892
New +$3.78M ﹤0.01% 2626

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Dimensional Fund Advisors's KYMR Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Kymera Therapeutics (KYMR) stake by 5% in Q1 2026, selling an estimated $2.47M and leaving 592,879 shares worth $49.4M. The position accounts for 0.01% of the portfolio, ranked #1504.

Dimensional Fund Advisors first reported a position in KYMR in Q4 2021 and has held it in 18 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Dimensional Fund Advisors held 592,879 shares of Kymera Therapeutics worth $49.4M as of Q1 2026.
  • Dimensional Fund Advisors sold 31,148 Kymera Therapeutics shares in Q1 2026, an estimated $2.47M.
  • Kymera Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1504 holding.
  • Dimensional Fund Advisors first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.